First and foremost, anything to come out of EATCOVID is a complete bonus for this company. I believe $0 of the current market cap has anything from the Covid trial built into it.
MSB released some data on their Covid trial, and a slide on their presentation showed a clear differential between the number of T Cells for patients who have an "average" Covid case and a "severe" Covid case. For average cases, it shows that patients T Cells are at a decent level. But when you go over to the picture for severe cases, the patients T Cell levels are completely obliterated.
I'm assuming 95% of people here know that Efti increased and activates a patients T Cell function, which could give to the possibility of when given Efti, severe cases of Covid could be minimised to a great extent.
Keen on an update from the company after seeing this development.
First and foremost, anything to come out of EATCOVID is a...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85852 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 75389 | 4 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |